Fidia S.p.A. (BIT:FDA)
0.0198
+0.0014 (7.61%)
Nov 2, 2026, 4:15 PM CET
Fidia Revenue
Fidia had revenue of 8.67M EUR in the half year ending June 30, 2026, a decrease of -25.15%. This brings the company's total for the last twelve months to 24.62M. In the year 2025, Fidia had annual revenue of 29.49M with 39.76% growth. That makes Fidia the 32,189th largest company in the world by revenue and 291st in Italy.
Revenue (ttm)
24.62M
Revenue Growth
+39.76%
P/S Ratio
0.98
Revenue / Employee
164.24K
Employees
143
Market Cap
24.74M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Fidia breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 29.49M | 8.39M | 39.76% |
| Dec 31, 2024 | 21.10M | -9.05M | -30.02% |
| Dec 31, 2023 | 30.15M | 5.54M | 22.52% |
| Dec 31, 2022 | 24.61M | 573.00K | 2.38% |
| Dec 31, 2021 | 24.03M | 2.27M | 10.43% |
| Dec 31, 2020 | 21.76M | -26.24M | -54.66% |
| Dec 31, 2019 | 48.00M | -10.91M | -18.52% |
| Dec 31, 2018 | 58.92M | 10.96M | 22.84% |
| Dec 31, 2017 | 47.96M | -11.66M | -19.56% |
| Dec 31, 2016 | 59.62M | -3.71M | -5.86% |
| Dec 31, 2015 | 63.33M | 6.02M | 10.51% |
| Dec 31, 2014 | 57.31M | 11.53M | 25.18% |
| Dec 31, 2013 | 45.78M | -3.94M | -7.93% |
| Dec 31, 2012 | 49.72M | 4.20M | 9.21% |
| Dec 31, 2011 | 45.53M | -3.24M | -6.64% |
| Dec 31, 2007 | 48.76M | 6.64M | 15.76% |
| Dec 31, 2006 | 42.13M | 7.21M | 20.64% |
| Dec 31, 2005 | 34.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danieli & C. Officine Meccaniche | 3.83B |
| Biesse | 650.82M |
| SIT S.p.A. | 316.17M |
| Tesmec | 273.24M |
| ILPRA | 91.65M |
| Marzocchi Pompe | 37.66M |
| OSAI Automation System | 34.56M |
| Valtecne | 31.43M |
Fidia News
- 1 day ago - Ajay Devgn's legal challenge won't halt proceedings, says Maharashtra FDA chief Tukaram Mundhe on Vimal Elaichi ad controversy - The Times of India
- 1 day ago - Why Doctors Are Last to Know What’s in the Drug Supply - TIME
- 1 day ago - FDA show-cause notice on ad is pre-judging, punitive: Actor Ajay Devgn - The Times of India
- 2 days ago - 'Prejudging, premeditated, punitive': Ajay Devgn hits out at FDA over pan masala ad notice - The Times of India
- 2 days ago - INOVIO Pharma Soars As FDA Grants Accelerated Approval For VOCERYQ In Adult RRP - Nasdaq
- 2 days ago - US FDA approves Inovio's treatment for rare throat disease - Reuters
- 2 days ago - Ajay Devgn moves HC over FDA’s pan masala ad notice - The Times of India
- 2 days ago - Maharashtra govt suspends four FDA officers, launches dept inquiry against 21 others over irregularities in action against two companies accused of possessing banned tobacco products - The Times of India